Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Forrer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 3, 2005
Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumoursF Forrer, J Mueller-Brand, H Maecke
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 16, 2008
Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytomaF Forrer, I Riedweg, H R Maecke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2007
Is it possible to predict renal function in small animals using a multi-pinhole SPECT systemF Forrer, E Rolleman, N Schramm, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 30, 2013
Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximabF Forrer, C Oechslin-Oberholzer, B Campana, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2004
A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumoursF Forrer, H Uusijärvi, C Waldherr, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 22, 2011
Sentinel lymph node biopsy in primary breast cancer: trust the radiolabeled colloid method and avoid unnecessary proceduresS M Schmid, M E Myrick, F Forrer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analoguesM A Muros, M Varsavsky, P Iglesias Rozas, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 10, 2007
Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapyM Melis, F Forrer, A Capello, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animalsF Forrer, R Valkema, B Bernard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2010
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trialD Cordier, F Forrer, F Bruchertseifer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine and Molecular Imaging|February 3, 2005
Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumoursF Forrer, J Mueller-Brand, H Maecke
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 16, 2008
Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytomaF Forrer, I Riedweg, H R Maecke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2007
Is it possible to predict renal function in small animals using a multi-pinhole SPECT systemF Forrer, E Rolleman, N Schramm, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 30, 2013
Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximabF Forrer, C Oechslin-Oberholzer, B Campana, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2004
A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumoursF Forrer, H Uusijärvi, C Waldherr, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 22, 2011
Sentinel lymph node biopsy in primary breast cancer: trust the radiolabeled colloid method and avoid unnecessary proceduresS M Schmid, M E Myrick, F Forrer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analoguesM A Muros, M Varsavsky, P Iglesias Rozas, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 10, 2007
Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapyM Melis, F Forrer, A Capello, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animalsF Forrer, R Valkema, B Bernard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2010
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trialD Cordier, F Forrer, F Bruchertseifer, et al.
Pageof 2